BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26573278)

  • 21. A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.
    Green MR; Jardine P; Wood P; Wellwood J; Lea RA; Marlton P; Griffiths LR
    BMC Cancer; 2010 May; 10():195. PubMed ID: 20462409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas.
    Rinaldi A; Kwee I; Poretti G; Mensah A; Pruneri G; Capello D; Rossi D; Zucca E; Ponzoni M; Catapano C; Tibiletti MG; Paulli M; Gaidano G; Bertoni F
    Br J Haematol; 2006 Jul; 134(1):27-36. PubMed ID: 16803564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative cases.
    Tagawa H; Tsuzuki S; Suzuki R; Karnan S; Ota A; Kameoka Y; Suguro M; Matsuo K; Yamaguchi M; Okamoto M; Morishima Y; Nakamura S; Seto M
    Cancer Res; 2004 Sep; 64(17):5948-55. PubMed ID: 15342373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced DNA repair and genomic stability identify a novel HIV-related diffuse large B-cell lymphoma signature.
    Maguire A; Chen X; Wisner L; Malasi S; Ramsower C; Kendrick S; Barrett MT; Glinsmann-Gibson B; McGrath M; Rimsza LM
    Int J Cancer; 2019 Dec; 145(11):3078-3088. PubMed ID: 31044434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma.
    Obermann EC; Csato M; Dirnhofer S; Tzankov A
    J Clin Pathol; 2009 Oct; 62(10):903-7. PubMed ID: 19783718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
    Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
    Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas.
    Jardin F; Ruminy P; Kerckaert JP; Parmentier F; Picquenot JM; Quief S; Villenet C; Buchonnet G; Tosi M; Frebourg T; Bastard C; Tilly H
    Haematologica; 2008 Apr; 93(4):543-50. PubMed ID: 18287131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1.
    Hoeller S; Schneider A; Haralambieva E; Dirnhofer S; Tzankov A
    Histopathology; 2010 Jul; 57(1):73-80. PubMed ID: 20579129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromosomal imbalances in diffuse large B-cell lymphoma detected by comparative genomic hybridization.
    Berglund M; Enblad G; Flordal E; Lui WO; Backlin C; Thunberg U; Sundström C; Roos G; Allander SV; Erlanson M; Rosenquist R; Larsson C; Lagercrantz S
    Mod Pathol; 2002 Aug; 15(8):807-16. PubMed ID: 12181265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast.
    Hawthorn L; Luce J; Stein L; Rothschild J
    BMC Cancer; 2010 Aug; 10():460. PubMed ID: 20799942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.
    Wright G; Tan B; Rosenwald A; Hurt EH; Wiestner A; Staudt LM
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9991-6. PubMed ID: 12900505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukemic presentation and progressive genomic alterations of MCD/C5 diffuse large B-cell lymphoma (DLBCL).
    Kim PM; Nejati R; Lu P; Thakkar D; Mackrides N; Dupoux V; Nakhoda S; Baldwin DA; Pei J; Dave SS; Wang YL; Wasik MA
    Cold Spring Harb Mol Case Stud; 2023 Dec; 9(4):. PubMed ID: 37730436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma.
    Nakamura S; Ye H; Bacon CM; Goatly A; Liu H; Kerr L; Banham AH; Streubel B; Yao T; Tsuneyoshi M; Savio A; Takeshita M; Dartigues P; Ruskoné-Fourmestraux A; Matsumoto T; Iida M; Du MQ
    Clin Cancer Res; 2008 May; 14(10):3002-10. PubMed ID: 18445693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
    Fu K; Weisenburger DD; Choi WW; Perry KD; Smith LM; Shi X; Hans CP; Greiner TC; Bierman PJ; Bociek RG; Armitage JO; Chan WC; Vose JM
    J Clin Oncol; 2008 Oct; 26(28):4587-94. PubMed ID: 18662967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations.
    Martinez-Climent JA; Alizadeh AA; Segraves R; Blesa D; Rubio-Moscardo F; Albertson DG; Garcia-Conde J; Dyer MJ; Levy R; Pinkel D; Lossos IS
    Blood; 2003 Apr; 101(8):3109-17. PubMed ID: 12406872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma.
    Rinaldi A; Capello D; Scandurra M; Greiner TC; Chan WC; Bhagat G; Rossi D; Morra E; Paulli M; Rambaldi A; Rancoita PM; Inghirami G; Ponzoni M; Moreno SM; Piris MA; Mian M; Chigrinova E; Zucca E; Favera RD; Gaidano G; Kwee I; Bertoni F
    Br J Haematol; 2010 May; 149(4):569-77. PubMed ID: 20230398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
    Marescalco MS; Capizzi C; Condorelli DF; Barresi V
    J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations or copy number losses of CD58 and TP53 genes in diffuse large B cell lymphoma are independent unfavorable prognostic factors.
    Cao Y; Zhu T; Zhang P; Xiao M; Yi S; Yang Y; Li Q; Ling S; Wang Y; Gao L; Zhu L; Wang J; Wang N; Huang L; Zhang P; Zhai Q; Qiu L; Zhou J
    Oncotarget; 2016 Dec; 7(50):83294-83307. PubMed ID: 27825110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma.
    Chang CC; Zhou X; Taylor JJ; Huang WT; Ren X; Monzon F; Feng Y; Rao PH; Lu XY; Fabio F; Hilsenbeck S; Creighton CJ; Jaffe ES; Lau CC
    J Hematol Oncol; 2009 Nov; 2():47. PubMed ID: 19909553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.
    Bea S; Zettl A; Wright G; Salaverria I; Jehn P; Moreno V; Burek C; Ott G; Puig X; Yang L; Lopez-Guillermo A; Chan WC; Greiner TC; Weisenburger DD; Armitage JO; Gascoyne RD; Connors JM; Grogan TM; Braziel R; Fisher RI; Smeland EB; Kvaloy S; Holte H; Delabie J; Simon R; Powell J; Wilson WH; Jaffe ES; Montserrat E; Muller-Hermelink HK; Staudt LM; Campo E; Rosenwald A;
    Blood; 2005 Nov; 106(9):3183-90. PubMed ID: 16046532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.